BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

MethylGene Inc. 

7220 Frederick-Banting
Suite 200
Montreal  Quebec  H4S 2A1  Canada
Phone: 514-337-3333 Fax: 514-337-0550


SEARCH JOBS




Collaborations

Merck & Co., Inc.  Antibacterials





 Company News
MethylGene Reports First Quarter 2013 Financial Results 5/13/2013 11:03:31 AM    More...
MethylGene Announces Plan to Reincorporate in the United States as Mirati Therapeutics, Inc. and List on the NASDAQ 5/9/2013 9:56:27 AM    More...
MethylGene Presents Preclinical Data on MG516 at the American Association for Cancer Research Annual Meeting 4/8/2013 11:56:09 AM    More...
MethylGene Reports Results of Phase 2 Trial of MGCD290 3/18/2013 12:04:55 PM    More...
MethylGene Announces Management Changes 3/14/2013 11:51:34 AM    More...
MethylGene Reports Fourth Quarter and Full Year 2012 Financial Results 3/13/2013 10:15:14 AM    More...
MethylGene Announces the Appointment of Mark J. Gergen, as Executive Vice President and COO 2/19/2013 11:45:43 AM    More...
MethylGene Completes Enrollment in Phase 2 Trial of MGCD290 12/19/2012 11:41:29 AM    More...
MethylGene to Present at the Piper Jaffray 24th Annual Healthcare Conference 11/21/2012 12:14:06 PM    More...
MethylGene Closes $26.1 Million Private Placement 11/21/2012 8:23:36 AM    More...
12345678910...